This compound is a chloroquinoline-containing alcohol used as a pharmaceutical intermediate. It is employed in the synthesis of active pharmaceutical ingredients, primarily for research and manufacturing purposes.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 142569-70-8
Fmoc-(2S,3R)-AHPA
Peptide synthesis building block
CARBAMIC ACID, N-[(1R)-2-[1,1'-BIPHENYL]-4-YL-1-(HYDROXYMETHYL)ETHYL]-, 1,1-DIMETHYLETHYL ESTER
Pharmaceutical intermediate for LCZ696
(R)-((2R,5R)-5-(4-aminobenzyl)pyrrolidin-2-yl)(phenyl)methanol
Pharmaceutical intermediate
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
Pharmaceutical intermediate for vericiguat synthesis
(S,E)-Methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hydroxypropyl)benzoate
pharmaceutical intermediate
(S,E)-Methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hydroxypropyl)benzoate
Pharmaceutical intermediate for montelukast
(1S)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propan-1-ol
ZSHIDKYITZZTLA-FCPABOFRSA-N
CC(C)(C1=CC=CC=C1CC[C@@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)O)O